Bionano Genomics Inc (BNGO) - News Archive

Pioneering a New Era: Bionano Genomics OGM Receives Preliminary CMS Payment DeterminationIn a significant development for genomic medicine, Bionano Laboratories, a subsidiary of Bionano Genomics, Inc. (NASDAQ: BNGO), an...

IntroductionBionano Genomics, Inc. (Nasdaq: BNGO) has made significant strides in the field of genetic diagnostics with its innovative Optical Genome Mapping (OGM) technology. Recent peer-reviewed publications highlight...

Optical Genome Mapping Outperforms Traditional Cytogenetic Assays in Bone and Soft Tissue Tumor Analysis: A Study by Johns Hopkins University Recent advancements in genetic analysis techniques have brought transformativ...

Bionano Genomics: Navigating Proxy Proposals and Promising Advancements in CytogeneticsIn recent months, Bionano Genomics Inc. has captured the attention of investors and stakeholders within the biotechnology sector as...

Navigating Uncertainty: Bionano Genomics Strategic Growth Amidst Stockholder DiscontentIn a notable development in the biotechnology sector, Bionano Genomics recently announced the adjournment of its Special Meeting of...

Bionano Genomics Adjourns Special Meeting Amidst $10 Million Offering: A Closer Look at the Company’s Strategic MovesBionano Genomics Inc. recently announced the adjournment of its special meeting of stockholders, now r...

Bionano Genomics, Inc. has announced its participation in the Cancer Genomics Consortium (CGC) 2024 Annual Meeting, showcasing the utility of optical genome mapping (OGM) in cancer research. This article reviews the sig...

In the ever-evolving landscape of cancer research, Bionano Genomics, Inc. has made promising strides with their groundbreaking optical genome mapping (OGM) technology. The company s recent publication showcases the util...

In a significant development, Bionano Genomics Inc. (Nasdaq: BNGO) has announced a substantial fundraising initiative of up to $30 million through a registered direct offering, alongside an upfront payment of $10 millio...

Certainly, here is an article suitable for CSIMarket.com : Bionano and Revvity s Strategic Software Partnership Set to Revolutionize Newborn Sequencing Research In a move that promises to reshape the landscape of newbor...

In a significant breakthrough in cancer research, Bionano Genomics Inc. has publicized the results of a study showcasing the efficacy of Optical Genome Mapping (OGM) in the detection of high-resolution structural variat...

In a revolutionary partnership that could potentially redefine cytogenetic analysis for reproductive health in China, two major players in the biotechnology world, Bionano and Diagens, have announced plans to commercial...

Genomic analysis plays a crucial role in understanding various diseases, particularly in pediatric oncology. Recent studies have highlighted the limitations of conventional techniques such as whole genome sequencing (WG...

In a bid to improve the diagnosis and understanding of solid tumor cancers, scientific researchers have reaffirmed the remarkable potential of optical genome mapping (OGM) to identify genetic aberrations that were previ...

Advancements in Optical Genome Mapping Provide Novel Insights into Prognosis, Tumor Progression, and Chemotherapy Resistance in Hereditary Breast and Ovarian Cancer SyndromeIn a recent study published in the esteemed jo...

Over the past twelve months, Bionano Genomics Inc. has made repayments on its liabilities, leading to an improvement in its trailing twelve months Leverage Ratio to 0.29, also below the company s average. Despite this i...

In recent years, the battle against cancer has become increasingly complex. The emergence of drug resistance poses significant challenges in effectively treating the disease. However, a groundbreaking study published in...

The paradigm of prenatal genetic disease testing is in the precipice of an important shift. Bionano Genomics, Inc., a leading pioneer in the field of genomic analysis, recently announced the publication of the second in...

Bionano Genomics, Inc., a leading genomics company, has recently announced the full commercial release of their Stratys system for high throughput optical genome mapping (OGM). This system is expected to revolutionize t...

In a groundbreaking development, Bionano, a leading genomics company, has announced the publication of a peer-reviewed study that reinforces the importance of Optical Genome Mapping (OGM) as an integral part of the Stan...